Guidance on PFAS Exposure, Testing, and Clinical Follow-Up

In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because...

Descripción completa

Detalles Bibliográficos
Autor principal: National Academies of Sciences, Engineering, and Medicine (-)
Autores Corporativos: National Academies of Sciences, Engineering, and Medicine, author (author), Health and Medicine Division, author, Division on Earth and Life Studies, author, Board on Population Health and Public Health Practice, author, Board on Environmental Studies and Toxicology, author, Committee on the Guidance on PFAS Testing and Health Outcomes, author
Otros Autores: Division, Health and Medicine, Studies, Division on Earth and Life, Practice, Board on Population Health and Public Health, Toxicology, Board on Environmental Studies and, Outcomes, Committee on the Guidance on PFAS Testing and Health
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press 2022.
Edición:1st ed
Materias:
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009733740306719
Descripción
Sumario:In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because they have properties that repel oil and water, reduce friction, and resist temperature changes. PFAS can leak into the environment where they are made, used, disposed of, or spilled. PFAS exposure has been linked to a number of adverse health effects including certain cancers, thyroid dysfunction, changes in cholesterol, and small reductions in birth weight.This report recommends that the Centers for Disease Control and Prevention (CDC) update its clinical guidance to advise clinicians to offer PFAS blood testing to patients who are likely to have a history of elevated exposure, such as those with occupational exposures or those who live in areas known to be contaminated. If testing reveals PFAS levels associated with an increased risk of adverse effects, patients should receive regular screenings and monitoring for these and other health impacts. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up recommends that the CDC, Agency for Toxic Substances and Disease Registry (ATSDR), and public health departments support clinicians by creating educational materials on PFAS exposure, potential health effects, the limitations of testing, and the benefits and harms of testing.
Descripción Física:1 online resource (301 pages)
ISBN:9780309482455